Zobrazeno 1 - 10
of 184
pro vyhledávání: '"Arun, Swaminath"'
Publikováno v:
Inflammatory Intestinal Diseases, Vol 9, Iss 1, Pp 252-259 (2024)
Introduction: A secondary loss of response (LOR) to infliximab (IFX) therapy for inflammatory bowel disease (IBD) is typically associated with low IFX trough levels, often with high levels of neutralizing antibodies to IFX (ATI). A small subset of pa
Externí odkaz:
https://doaj.org/article/7aa8a7802e834a0788aa33ba3255fc77
Autor:
Youran Gao, Meka Uffenheimer, Michael Ashamallah, Gregory Grimaldi, Arun Swaminath, Keith Sultan
Publikováno v:
Intestinal Research, Vol 18, Iss 3, Pp 289-296 (2020)
Background/Aims Inflammatory bowel disease (IBD) involves chronic inflammation of the colon with ulcerative colitis (UC), and the colon and/or small intestine with Crohn’s disease (CD). Pneumatosis intestinalis (PI), characterized by compromise of
Externí odkaz:
https://doaj.org/article/71f73d4c022046a59794e454a2301a14
Autor:
Ellen A. Oseni, Miriam Blumenthal, Stephanie Izard, Michael Qiu, Anjali Mone, Arun Swaminath, Keith Sultan
Publikováno v:
Journal of Clinical Medicine Research. 15:99-108
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee0aa229549de70e5c899561627f98bd
https://doi.org/10.14740/jocmr4846
https://doi.org/10.14740/jocmr4846
Publikováno v:
Therapeutics and Clinical Risk Management. 18:913-927
Inflammatory bowel disease (IBD), namely Ulcerative Colitis (UC) and Crohn's Disease (CD), is believed to be due to a dysregulation of the innate immune response. The complexity of the immune cascade offers both a challenge and an opportunity to rese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f351dd0c80f9322b3439fb32227c518a
https://doi.org/10.2147/tcrm.s336139
https://doi.org/10.2147/tcrm.s336139
Publikováno v:
American Journal of Therapeutics. 30:e288-e291
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff9b1c878cd34c10263400c1e20abe7c
https://doi.org/10.1097/mjt.0000000000001534
https://doi.org/10.1097/mjt.0000000000001534
Publikováno v:
Current Opinion in Gastroenterology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::038723e8f5ce0429a5e512e283511653
https://doi.org/10.1097/mog.0000000000000946
https://doi.org/10.1097/mog.0000000000000946
Autor:
Daryl Ramai, Peter Bhandari, Anjali Kewalramani, Daniel Mozell, Saurabh Chandan, Antonio Facciorusso, Paraskevas Gkolfakis, Arun Swaminath, Douglas G. Adler
Publikováno v:
Esophagus.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53d730a7637b5f32a1d1ac2f412c01a0
https://doi.org/10.1007/s10388-023-01007-x
https://doi.org/10.1007/s10388-023-01007-x
Autor:
Simcha Weissman, Brian M. Fung, Ayrton Bangolo, Atif Rashid, Badar F. Khan, Aditya K. Gudimella Tirumala, Sneha Nagpaul, Samuel Cornwell, Praveena Karamthoti, Vignesh Murugan, Ihsan S. Taranichi, Maksim Kalinin, Annetta Wishart, Ibtihal Khalaf, Naga A. Kodali, Pruthvi S. C. Aluri, Yabets Kejela, Rub Abdul, Feba M. Jacob, Advaith Manoharasetty, Aparna Sethi, Preethi M. Nadimpallli, Natalia P. Ballestas, Aarushi Venkatraman, Avinash Chirumamilla, Vignesh K. Nagesh, Manesh K. Gangwani, Kelly Issokson, Muhammad Aziz, Arun Swaminath, Joseph D. Feuerstein
Publikováno v:
International Journal of Colorectal Disease. 38
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a77e100fb6a6795725f821ef88c471ea
https://doi.org/10.1007/s00384-023-04404-x
https://doi.org/10.1007/s00384-023-04404-x
Autor:
Yiran Zhang, Satimai Aniwan, A Weiss, Gursimran Kochhar, Sunanda V. Kane, Bo Shen, Matthew Bohm, Siddharth Singh, Eugenia Shmidt, Jean-Frederic Colombel, Corey A. Siegel, David Faleck, Edward V. Loftus, James P. Campbell, Mahmoud A. Rahal, Siri Kadire, Ronghui Xu, William J. Sandborn, David Hudesman, Arun Swaminath, Joseph Meserve, Robert Hirten, Vipul Jairath, Ryan C. Ungaro, Bruce E. Sands, Karen Lasch, Jenna L. Koliani-Pace, Brigid S. Boland, Parambir S. Dulai, Dana J. Lukin, Shreya Chablaney, Monika Fischer, Adam Winters, Gloria Tran, Shannon Chang, Sashidhar Varma
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol 20, iss 1
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol 20, iss 1
Background & Aims We aimed to compare safety and effectiveness of vedolizumab to tumor necrosis factor (TNF)-antagonist therapy in ulcerative colitis in routine practice. Methods A multicenter, retrospective, observational cohort study (May 2014 to D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::083dd325756fdb07317c52afa6118590
https://doi.org/10.1016/j.cgh.2020.10.003
https://doi.org/10.1016/j.cgh.2020.10.003
Autor:
Keith, Sultan, Laura, Durbin, Richa, Bhardwaj, James, Mackey, Noah, Becher, Mohammad, Abureesh, Komal, Lakhani, Anjali, Mone, Jeffrey, Abergel, Arvind, Trindade, Burton I, Korelitz, Arun, Swaminath
Publikováno v:
Gastroenterology Research
Background To date, studies investigating the inflammatory bowel disease (IBD) patient experience with coronavirus disease 2019 (COVID-19) have consistently reported that the observed rate of COVID-19 within this population is similar to the general
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e54bbb5133656221cd606bee0b6a0bd4
https://doi.org/10.14740/gr1447
https://doi.org/10.14740/gr1447